| Dr Adriana Jadranka Pavletic, MD | |
|
10 Center Drive Mcs 1276, Crc- Room 6-5340, Bethesda, MD 20892-0001 | |
| (301) 594-7386 | |
| Not Available |
| Full Name | Dr Adriana Jadranka Pavletic |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 10 Center Drive Mcs 1276, Bethesda, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245536739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20098 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adriana Jadranka Pavletic, MD 10 Center Drive Mcs 1276, Crc- Room 6-5340, Bethesda, MD 20892-0001 Ph: (301) 594-7386 | Dr Adriana Jadranka Pavletic, MD 10 Center Drive Mcs 1276, Crc- Room 6-5340, Bethesda, MD 20892-0001 Ph: (301) 594-7386 |
News Archive
A new toll-free helpline developed to help pregnant women avoid medications and other substances that can cause birth defects has been launched by The University of Texas Health Science Center at Houston (UTHealth) for the Texas Department of State Health Services.
At an inquest into his death the dangers of body piercing were underlined by a coroner following the death of the student from blood poisoning two months after having a ring put through his lip.
Researchers have identified a compound that mimics one of the brain's own growth factors and can protect brain cells against damage in several animal models of neurological disease.
New data presented at the 6th Pan Asian Committee for Treatment and Research in Multiple Sclerosis, show positive preliminary results from PERSIST, a 12-month, Phase 4 clinical study of once weekly Avonex Pen for patients with relapsing-remitting multiple sclerosis.
Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.
› Verified 4 days ago
Elyse Fiore Pierre, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4301 Jones Bridge Rd, Bethesda, MD 20814 Phone: 301-295-3630 | |
Eva Maria Morell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4977 Battery Lane, Suite 209, Bethesda, MD 20814 Phone: 301-469-9028 | |
Dr. Steven Wilks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8600 Old Georgetown Rd, Attn: Medical Staff Office/angela Speck, Bethesda, MD 20814 Phone: 301-896-3100 Fax: 301-897-1378 | |
Ms. Jessica Temple Servey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4301 Jones Bridge Rd, Bethesda, MD 20814 Phone: 301-295-9470 Fax: 301-295-9470 | |
Dr. Susan Yanovski, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9000 Rockville Pike, Bethesda, MD 20892 Phone: 301-221-8402 | |
Dr. Jean-pierre Marcel Faure, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8218 Wisconsin Ave, Ste P 9, Bethesda, MD 20814 Phone: 301-656-0128 Fax: 301-656-3429 | |
Dr. M Linda M Thompson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 8218 Wisconsin Ave, Suite 215, Bethesda, MD 20814 Phone: 301-652-5454 Fax: 301-652-4888 |